Effectiveness and adverse drug reactions of levetiracetam and midazolam in refractory neonatal seizure: A cross-sectional comparative study
BACKGROUND: Neonatal seizure (NS) reflects serious underlying brain injury, requiring immediate evaluation and early treatment. In neonates, phenobarbitone and phenytoin are used primarily to control the seizures. If uncontrolled, widespread off-label use of midazolam and levetiracetam was practiced...
Saved in:
Main Authors: | Diptiman Jayswal (Author), Uttam Kumar Roy (Author), Taraknath Ghosh (Author), Purnendu Mandal (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Midazolam in Refractory Neonatal Seizures
by: J Gordon Millichap
Published: (2005) -
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
by: Jae Won Shin, et al.
Published: (2017) -
Levetiracetam as the First-line Antiepileptic in Neonatal Seizures
by: Hari Prasath Ramachandran, et al.
Published: (2020) -
Efficacy of levetiracetam for neonatal seizures in preterm infants
by: Ji Yoon Han, et al.
Published: (2018) -
Levetiracetam in Partial Seizures
by: J Gordon Millichap
Published: (2002)